Literature DB >> 15929726

Role of chirality in peptide-induced formation of cholesterol-rich domains.

Richard M Epand1, Scott D Rychnovsky, Jitendra D Belani, Raquel F Epand.   

Abstract

The chiral specificity of the interactions of peptides that induce the formation of cholesterol-rich domains has not been extensively investigated. Both the peptide and most lipids are chiral, so there is a possibility that interactions between peptide and lipid could require chiral recognition. On the other hand, in our models with small peptides, the extent of folding of the peptide to form a specific binding pocket is limited. We have determined that replacing cholesterol with its enantiomer, ent-cholesterol, alters the modulation of lipid organization by peptides. The phase-transition properties of SOPC (1-stearoyl-2-oleoylphosphatidylcholine):cholesterol [in a 6:4 ratio with 0.2 mol% PtdIns(4,5)P2] are not significantly altered when ent-cholesterol replaces cholesterol. However, in the presence of 10 mol% of a 19-amino-acid, N-terminally myristoylated fragment (myristoyl-GGKLSKKKKGYNVNDEKAK-amide) of the protein NAP-22 (neuronal axonal membrane protein), the lipid mixture containing cholesterol undergoes separation into cholesterol-rich and cholesterol-depleted domains. This does not occur when ent-cholesterol replaces cholesterol. In another example, when N-acetyl-Leu-Trp-Tyr-Ile-Lys-amide (N-acetyl-LWYIK-amide) is added to SOPC:cholesterol (7:3 ratio), there is a marked increase in the transition enthalpy of the phospholipid, indicating separation of a cholesterol-depleted domain of SOPC. This phenomenon completely disappears when ent-cholesterol replaces cholesterol. The all-D-isomer of N-acetyl-LWYIK-amide also induces the formation of cholesterol-rich domains with natural cholesterol, but does so to a lesser extent with ent-cholesterol. Thus specific peptide chirality is not required for interaction with cholesterol-containing membranes. However, a specific chirality of membrane lipids is required for peptide-induced formation of cholesterol-rich domains.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15929726      PMCID: PMC1198934          DOI: 10.1042/BJ20050649

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells.

Authors:  David A Zacharias; Jonathan D Violin; Alexandra C Newton; Roger Y Tsien
Journal:  Science       Date:  2002-05-03       Impact factor: 47.728

2.  Enantiospecificity of cholesterol function in vivo.

Authors:  C M Crowder; E J Westover; A S Kumar; R E Ostlund; D F Covey
Journal:  J Biol Chem       Date:  2001-10-11       Impact factor: 5.157

3.  Hadrurin, a new antimicrobial peptide from the venom of the scorpion Hadrurus aztecus.

Authors:  A Torres-Larios; G B Gurrola; F Z Zamudio; L D Possani
Journal:  Eur J Biochem       Date:  2000-08

4.  Stereoselective recognition of monolayers of cholesterol, ent-cholesterol, and epicholesterol by an antibody.

Authors:  M Geva; D Izhaky; D E Mickus; S D Rychnovsky; L Addadi
Journal:  Chembiochem       Date:  2001-04-02       Impact factor: 3.164

5.  D-enantiomer peptide of the TCRalpha transmembrane domain inhibits T-cell activation in vitro and in vivo.

Authors:  Doron Gerber; Francisco J Quintana; Itai Bloch; Irun R Cohen; Yechiel Shai
Journal:  FASEB J       Date:  2005-04-18       Impact factor: 5.191

6.  Protein-induced formation of cholesterol-rich domains.

Authors:  R M Epand; S Maekawa; C M Yip; R F Epand
Journal:  Biochemistry       Date:  2001-09-04       Impact factor: 3.162

7.  Nuclear Overhauser enhancement spectroscopy cross-relaxation rates and ethanol distribution across membranes.

Authors:  Scott E Feller; Christopher A Brown; David T Nizza; Klaus Gawrisch
Journal:  Biophys J       Date:  2002-03       Impact factor: 4.033

8.  Antibacterial activities of temporin A analogs.

Authors:  D Wade; J Silberring; R Soliymani; S Heikkinen; I Kilpeläinen; H Lankinen; P Kuusela
Journal:  FEBS Lett       Date:  2000-08-11       Impact factor: 4.124

9.  Effects of cholesterol and enantiomeric cholesterol on P-glycoprotein localization and function in low-density membrane domains.

Authors:  G D Luker; C M Pica; A S Kumar; D F Covey; D Piwnica-Worms
Journal:  Biochemistry       Date:  2000-07-04       Impact factor: 3.162

10.  Cholesterol binding at the cholesterol recognition/ interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide.

Authors:  H Li; Z Yao; B Degenhardt; G Teper; V Papadopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-23       Impact factor: 11.205

View more
  4 in total

1.  Identification of a cholesterol-binding pocket in inward rectifier K(+) (Kir) channels.

Authors:  Oliver Fürst; Colin G Nichols; Guillaume Lamoureux; Nazzareno D'Avanzo
Journal:  Biophys J       Date:  2014-12-16       Impact factor: 4.033

2.  A concise synthesis of ent-Cholesterol.

Authors:  Jitendra D Belani; Scott D Rychnovsky
Journal:  J Org Chem       Date:  2008-03-13       Impact factor: 4.354

Review 3.  ent-Steroids: novel tools for studies of signaling pathways.

Authors:  Douglas F Covey
Journal:  Steroids       Date:  2008-12-03       Impact factor: 2.668

4.  Enantioselective protein-sterol interactions mediate regulation of both prokaryotic and eukaryotic inward rectifier K+ channels by cholesterol.

Authors:  Nazzareno D'Avanzo; Krzysztof Hyrc; Decha Enkvetchakul; Douglas F Covey; Colin G Nichols
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.